Literature DB >> 21362043

Effects of short-course androgen therapy on the neurodevelopmental profile of infants and children with 49,XXXXY syndrome.

Carole A Samango-Sprouse1, Andrea L Gropman, Teresa Sadeghin, Madison Kingery, Margaret Lutz-Armstrong, Alan D Rogol.   

Abstract

AIM: The aim of this investigation was to ascertain whether an early course of androgen treatment (three injections testosterone enanthate, 25 mg) could have a positive impact on any domains of neurodevelopmental function in boys with 49,XXXXY.
METHODS: A total of 22 boys with a karyotype of 49,XXXXY participated in a multidisciplinary assessment of neurocognition, speech and language, paediatric neurology and endocrinology evaluations. One group had received early androgen and another group did not receive any hormonal treatment prior to the evaluation. The mean age of treatment for Group 1 was 12 months with the mean age of first evaluation 74 months. The mean age of first evaluation for Group 2 was 87 months. Statistical analysis was completed to determine whether there was a positive treatment effect from androgen therapy.
RESULTS: There was a significant positive treatment effect in speech and language domain, gestural communication and vocabulary development. No treatment effect was seen on nonverbal capacities.
CONCLUSION: Our findings revealed improved function in several areas of development which had been severely delayed in boys with 49,XXXXY. Continued research is underway to expand our understanding of the relationship of androgen, brain function and behavioural outcome in boys with 49,XXXXY.
© 2011 The Author(s)/Acta Paediatrica © 2011 Foundation Acta Paediatrica.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21362043     DOI: 10.1111/j.1651-2227.2011.02252.x

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  9 in total

1.  Fluid intelligence, traits of personality and personality disorders in a cohort of adult KS patients with the classic 47, XXY karyotype.

Authors:  D Liberato; S Granato; D Grimaldi; F M Rossi; N Tahani; D Gianfrilli; A Anzuini; A Lenzi; G Cavaggioni; A F Radicioni
Journal:  J Endocrinol Invest       Date:  2017-04-11       Impact factor: 4.256

2.  Severe myelinopathy in 49,XXXXY syndrome.

Authors:  Mark A Buller; Cory M Pfeifer
Journal:  Neuroradiol J       Date:  2017-06-19

Review 3.  Effects of the Timing of Sex-Steroid Exposure in Adolescence on Adult Health Outcomes.

Authors:  Yee-Ming Chan; Amalia Feld; Elfa Jonsdottir-Lewis
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

4.  SNP-based non-invasive prenatal testing detects sex chromosome aneuploidies with high accuracy.

Authors:  Carole Samango-Sprouse; Milena Banjevic; Allison Ryan; Styrmir Sigurjonsson; Bernhard Zimmermann; Matthew Hill; Megan P Hall; Margaret Westemeyer; Jennifer Saucier; Zachary Demko; Matthew Rabinowitz
Journal:  Prenat Diagn       Date:  2013-06-20       Impact factor: 3.050

Review 5.  Sexual differentiation of the brain in man and animals: of relevance to Klinefelter syndrome?

Authors:  Margaret M McCarthy
Journal:  Am J Med Genet C Semin Med Genet       Date:  2013-01-18       Impact factor: 3.908

6.  Adverse pathophysiological influence of early testosterone therapy on the testes of boys with higher grade sex chromosome aneuploidies (HGAs): a retrospective, cross-sectional study.

Authors:  M Spaziani; C Tarantino; C Pozza; A Anzuini; F Panimolle; G Papi; D Gianfrilli; A Lenzi; A F Radicioni
Journal:  J Endocrinol Invest       Date:  2020-10-24       Impact factor: 4.256

7.  An infant born to a mother with gestational diabetes presenting with 49,XXXXY syndrome and renal agenesis-a case report.

Authors:  Dulika Sumathipala; Thilini Gamage; Bandula Wijesiriwardena; Rohan W Jayasekara; Vajira H W Dissanayake
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-10-02

8.  The Sex Chromosome Trisomy mouse model of XXY and XYY: metabolism and motor performance.

Authors:  Xuqi Chen; Shayna M Williams-Burris; Rebecca McClusky; Tuck C Ngun; Negar Ghahramani; Hayk Barseghyan; Karen Reue; Eric Vilain; Arthur P Arnold
Journal:  Biol Sex Differ       Date:  2013-08-08       Impact factor: 5.027

9.  Testosterone replacement in 49,XXXXY syndrome: andrological, metabolic and neurological aspects.

Authors:  Rossella Mazzilli; Michele Delfino; Jlenia Elia; Francesco Benedetti; Laura Alesi; Luciana Chessa; Fernando Mazzilli
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-12-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.